hydration dripin al mutawaa.

The fluid itself matters more than most marketing admits. The workhorse is 0.9 per cent sodium chloride — normal saline — which is mixed to roughly match the osmolality of your blood, meaning it neither pulls water out of your cells nor floods them. Some providers use lactated Ringer's or Hartmann's solution instead, which adds potassium, calcium and lactate in proportions closer to plasma. Everything else on the menu — vitamin cocktails, glutathione, NAD+ — is an additive dissolved into one of these carrier fluids.

Here is the honest part: for a healthy adult who is mildly dehydrated and can keep fluids down, oral rehydration works nearly as well and costs a few dirhams at any pharmacy. IV therapy earns its keep when the gut route is compromised — vomiting, severe nausea, heat exhaustion — or when someone wants rapid rehydration with electrolytes after significant fluid loss. A good provider will tell you this. A provider who insists a drip is always superior to drinking is selling, not advising.

Strip the menu names away and most UAE drip offerings reduce to a short list. The base is 500 ml to 1 litre of normal saline or Ringer's solution — this is the part with the strongest evidence, because fluid and electrolyte replacement is a century-old, well-understood therapy. On top of that, providers add B-complex vitamins (involved in energy metabolism, genuinely useful if you are deficient, otherwise excreted), vitamin C (modest evidence at normal doses; high-dose infusions require a doctor's order), magnesium (muscle cramps, migraine-adjacent uses), zinc, and anti-nausea or pain medication where a physician has prescribed it.

Then there is the premium shelf: glutathione, marketed for skin brightening, and NAD+, marketed for energy and longevity. The candid position — the one a good doctor will give you off the record — is that evidence for the cosmetic and anti-ageing claims is thin, and regulators in several countries have pushed back on skin-lightening glutathione marketing specifically. These infusions are not necessarily unsafe when properly administered, but you are paying AED 800–1,500 for something whose benefit is substantially less proven than the saline it is dissolved in. Buy them with clear eyes.

The second is phlebitis — irritation or inflammation of the vein, showing up as a red, warm, tender streak along the vein's path, sometimes a day later. Certain additives are more irritating than plain fluids, which again rewards slower infusion rates. The third is the vasovagal response: some people faint around needles, full stop. It is a reflex, not a weakness, and the mitigation is simple — you should always be infused lying down or well reclined, never perched on a bar stool. A nurse who checks whether you have fainted before, and positions you accordingly, has done this many times.

Two reassurances backed by physiology: the small air bubbles you may see in the line are not the movie scenario — it takes a large volume of air to cause harm, far beyond what tubing bubbles contain. And infection risk at the insertion site is genuinely low when asepsis is followed: skin cleaned with chlorhexidine or alcohol and allowed to dry, gloves, single-use everything, and a sharps container that the nurse brings and takes away. Watch for that sharps box — its absence is a red flag you can spot from across the room.